Article
Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors.
Journal of the National Comprehensive Cancer Network : JNCCN - 1 Mar 2018
Zaid Mohammad Abu, Gathirua-Mwangi Wambui G, Fung Chunkit, Monahan Patrick O, El-Charif Omar, Williams Annalynn M, Feldman Darren R, Hamilton Robert J, Vaughn David J, Beard Clair J, Cook Ryan, Althouse Sandra K, Ardeshir-Rouhani-Fard Shirin, Dinh Paul C, Sesso Howard D, Einhorn Lawrence H, Fossa Sophie D, Travis Lois B
Abstract excerpt
Background: Testicular cancer survivors (TCS) are at significantly increased risk for cardiovascular disease (CVD), with metabolic syndrome (MetS) an established risk factor. No study has addressed clinical and genetic MetS risk factors in North American TCS. Patients and Methods: TCS were aged <55 years at diagnosis and received first-line chemotherapy. Patients underwent physical examination, and had lipid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.